Assuming 30 trading days horizon, Insite Vision Inc. is expected to generate 0.54 times more return on investment than Adamis. However, Insite Vision Inc. is 1.85 times less risky than Adamis. It trades about -0.01 of its potential returns per unit of risk. Adamis Pharmaceuticals Corporation is currently generating about -0.01 per unit of risk. If you would invest 37.00 in Insite Vision Inc. on April 26, 2012 and sell it today you would lose (2.00) from holding Insite Vision Inc. or give up 5.41% of portfolio value over 30 days.
Diversification
Very good diversification
Overlapping area represents amount of risk that can be diversified away by holding Insite Vision Inc. and Adamis Pharmaceuticals Corp. in the same portfolio (assuming nothing else is changed)
Over the last 30 days Adamis Pharmaceuticals Corporation has generated negative risk-adjusted returns adding no value to investors with long positions.